Literature DB >> 8667016

Dual signalling by the adenosine A2a receptor involves activation of both N- and P-type calcium channels by different G proteins and protein kinases in the same striatal nerve terminals.

A K Gubitz1, L Widdowson, M Kurokawa, K A Kirkpatrick, P J Richardson.   

Abstract

Many Gs-linked receptors have been reported to use multiple signalling pathways in transfected cels but few in their normal cell environment. We show that the adenosine A2a receptor uses two signalling pathways to increase the release of acetylcholine from striatal nerve terminals. One pathway involves activation of Gs, adenylyl acylase, protein kinase A, and P-type calcium channels; the other is mediated by a cholera toxin-insensitive G protein, protein kinase C, and N-type calcium channels. The effects of these two pathways are not additive, the second pathway being inhibited by the first; but they are equally sensitive to the A2a receptor antagonist KF17837. This demonstrates that the A2a receptor activates two signalling systems in striatal cholinergic neurons.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8667016     DOI: 10.1046/j.1471-4159.1996.67010374.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  19 in total

1.  A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice.

Authors:  J F Chen; Z Huang; J Ma; J Zhu; R Moratalla; D Standaert; M A Moskowitz; J S Fink; M A Schwarzschild
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

2.  Presynaptic adenosine A2A receptors enhance GABAergic synaptic transmission via a cyclic AMP dependent mechanism in the rat globus pallidus.

Authors:  Tomomi Shindou; Hiromi Nonaka; Peter J Richardson; Akihisa Mori; Hiroshi Kase; Michio Ichimura
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

Review 3.  Neurotransmitter receptor heteromers and their integrative role in 'local modules': the striatal spine module.

Authors:  Sergi Ferré; Luigi F Agnati; Francisco Ciruela; Carme Lluis; Amina S Woods; Kjell Fuxe; Rafael Franco
Journal:  Brain Res Rev       Date:  2007-01-27

Review 4.  An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors.

Authors:  S Ferré; C Quiroz; A S Woods; R Cunha; P Popoli; F Ciruela; C Lluis; R Franco; K Azdad; S N Schiffmann
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

5.  The adenosine receptor agonist, APNEA, increases calcium influx into rat cortical synaptosomes through N-type channels associated with A2a receptors.

Authors:  S N Li; P T Wong
Journal:  Neurochem Res       Date:  2000-04       Impact factor: 3.996

6.  Adenosine A1 receptors modulate high voltage-activated Ca2+ currents and motor pattern generation in the xenopus embryo.

Authors:  P Brown; N Dale
Journal:  J Physiol       Date:  2000-06-15       Impact factor: 5.182

Review 7.  Impact of Coffee and Cacao Purine Metabolites on Neuroplasticity and Neurodegenerative Disease.

Authors:  Simonetta Camandola; Natalie Plick; Mark P Mattson
Journal:  Neurochem Res       Date:  2018-02-08       Impact factor: 3.996

8.  Adenosine A2A receptor in the monkey basal ganglia: ultrastructural localization and colocalization with the metabotropic glutamate receptor 5 in the striatum.

Authors:  James W Bogenpohl; Stefanie L Ritter; Randy A Hall; Yoland Smith
Journal:  J Comp Neurol       Date:  2012-02-15       Impact factor: 3.215

9.  Release inhibitory receptors activation favours the A2A-adenosine receptor-mediated facilitation of noradrenaline release in isolated rat tail artery.

Authors:  Paula Fresco; Carmen Diniz; Glória Queiroz; Jorge Gonçalves
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

10.  Functional histamine H3 and adenosine A2A receptor heteromers in recombinant cells and rat striatum.

Authors:  Ricardo Márquez-Gómez; Meridith T Robins; Citlaly Gutiérrez-Rodelo; Juan-Manuel Arias; Jesús-Alberto Olivares-Reyes; Richard M van Rijn; José-Antonio Arias-Montaño
Journal:  Pharmacol Res       Date:  2017-12-05       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.